← Latest venture news

F-Prime investment portfolio and recent venture funding rounds

🔗

fprimecapital.com

T-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease Extension Biotechnology

Nov 13, 2025

🔗

t-therapeutics.com

Charm Therapeutics raises £60m Series B led by NEA and SR One to advance next generation cancer drug Series B Biotechnology

Sep 2, 2025

🔗